Watson Increases its European Presence with US$563 M Specifar Acquisition
By Heather Cartwright
Pharma Deals Review: Vol 2011 Issue 6 (Table of Contents)
Published: 9 Jun-2011
DOI: 10.3833/pdr.v2011.i6.1480 ISSN: 1756-7874
Section: Mergers & Acquisitions
Fulltext:
Abstract
In order to expand in Europe, Watson Pharmaceuticals has acquired Specifar, one of the top 5 branded generics developers in Greece, for €400 M (US$563 M)...
This page is available to subscribers only.
Not a subscriber? Join here
Already Registered? Please login using the top left purple box.
Copyright: © IQVIA 2018
RSS